Three Tips for Achieving Better Reading Comprehension

Reading Comprehension pic
Reading Comprehension
Image: thoughtco.com

Based in New York, Ellen Scharaga is an operational consultant for Alegria Specialty Pharmacy, a company that assists patients and physicians alike by developing new medicine for treating chronic ailments. In her leisure time, Ellen Scharaga pursues a variety of interests, such as reading.

Reading carries with it a number of benefits, including stress reduction. People can make their reading time even more valuable by learning how to maximize their comprehension levels. Here are a few tips:

1. Monitor endurance

Next time you sit down with a book, read as you do normally but pay attention to when your focus starts to fade. Determine the time span and use that as a baseline. If the time was 20 minutes, for example, begin reading in 20-minute increments and slowly start increasing the time each day. This will help build reading endurance.

2. Keep a vocabulary list

Unfamiliar words can create a major barrier to reading comprehension. One strategy is to begin keeping a vocabulary list, noting not only definitions but also the context in which each word appears. By learning more words, readers can turn obstacles into strong points as they continue reading.

3. Read out loud

Another issue that limits or prevents reading comprehension is the mental distractions that occur. This can happen very easily because people mostly read silently. To address this issue, try reading out loud, which helps the brain focus more closely on the task at hand.

Advertisements

Common Early Symptoms of Multiple Sclerosis

Multiple Sclerosis pic
Multiple Sclerosis
Image: webmd.com

Ellen Scharaga serves as an operational consultant for Alegria Specialty Pharmacy. In this capacity, she ensures all stakeholders, patients, and managed care providers are given a platform to improve patient outcomes. Ellen Scharaga also helps with the development of specialty medications that manage such conditions as multiple sclerosis (MS).

An immune-mediated and progressive disorder, MS is often accompanied by several common signs. Some of the early symptoms of MS include:

Vision problems. Blurry vision, pain in the eye, and dull colors are all possible signs of MS. Over the course of several weeks or months, these vision problems may correct themselves. For this reason, patients should see a physician immediately if they begin having these problems to rule out MS as the possible cause.

Fatigue and weakness. Whether a person has been active or not, they may begin feeling extremely tired if they have MS. Fatigue affects roughly 80 percent of patients with early-stage MS. It often starts suddenly and lasts for weeks before going away. In addition to fatigue, many patients experience weakness in their legs.

Numbness and tingling. Since MS affects the nerves in the spinal cord and brain, individuals may experience strange sensations around their body. In most cases, numbness and tingling are experienced in the legs, fingers, face, and arms. However, some patients may also experience severe itching or the feeling of being shocked with electricity when moving their head.

AMCP Hosts its Managed Care and Specialty Pharmacy Annual Meeting

 

AMCP pic
AMCP
Image: AMCP.org

Since 2014 Ellen Scharaga has served as an operational consultant at Alegria Specialty Pharmacy. In this capacity, she helps the company to develop and deliver specialty medications for a wide range of chronic conditions and to promote improved patient outcomes. Active within the professional community, Ellen Scharaga belongs to the Academy of Managed Care Pharmacy (AMCP).

In 2017 AMCP, the leading association dedicated to improving patient health outcomes, held its Managed Care and Specialty Pharmacy Annual Meeting in Denver, Colorado. Lasting from March 27 to March 30, the event welcomed 4,000 professionals and stakeholders from throughout the United States.

The meeting kicked off on Monday with a pre-meeting Specialty Pharmacy Connect event that explored new innovations for specialty pharmacies to improve their spending management. AMCP began its general session the following day, featuring keynote addresses from such notable professionals as Derreck Kayongo, the CEO of the Center for Civil and Human Rights and the founder of the Global Soap Project.

Over the next several days, attendees participated in numerous industry workshops and student programs. The event also featured more than 40 educational sessions covering a wide range of topics, such as business trends in managed care and formulary management. In addition to these activities, the Annual Meeting hosted over 100 exhibitors at its Expo hall and offered nine independent satellite symposia.

Cancer Patients and the Affordable Care Act

 

Hope Lodges pic
Hope Lodges
Image: cancer.org

Based in Melville, NY, Ellen Scharaga is a professional in the pharmaceutical industry. She works as an operational consultant for Alegria Specialty Pharmacy. In addition, Ellen Scharaga supports the American Cancer Society.

The American Cancer Society raises funds to support cancer research and treatment. The organization also shares resources with cancer patients and their families. These resources include a health insurance assistance service (HIAS) that helps patients and their caregivers determine which insurance options offered in the Affordable Care Act are right for them.

American Cancer Society studies have revealed that people who have health insurance coverage have a lower likelihood of being diagnosed with late-stage disease and a higher likelihood of surviving the disease. This makes the Affordable Care Act especially relevant.

The provisions of the Affordable Care Act include preventive screening and treatment, as well as follow-up care. In addition, the new healthcare law provides better training to healthcare professionals who manage cancer pain and symptoms, allowing them to offer a higher quality of life to their patients.

OncoMed Senior VP of Operations Ellen Scharaga

From 1997 through 2009 Ellen Scharaga was the Vice President of Pharmacy Services at Group Health, Inc. Ellen was responsible for the direction and implementation of all pharmacy, home infusion and specialty injectable PPO, HMO, Medicare Part D and Government Programs. The responsibilities included contract negotiation, maximizing effectiveness and profitability, pharmacy vendor and specialty contract relationships, formulary administration, utilization management and integration of medical management cost initiatives. Ellen served as the primary advisor on all pharmacology-related matters including new product development and member and provider relations.

In addition, Ellen provided training support to sales associates, assisted in completion of RFP’s and conducts presentations to key accounts with the goal of quality services, profitability, retaining existing business and assisting in selling new business, distinguishing the pharmacy management program in the marketplace. Ellen has reported to the Chief Medical Officer; external contacts include physicians, healthcare professionals, executives of pharmacy benefit managers (PBM), trade and professional organizations and pharmaceutical manufacturers.

American Cancer Society Hope Lodges Make Traveling Easier

 

Hope Lodges pic
Hope Lodges
Image: cancer.org

For more than three decades, Ellen Scharaga has been a leader in the pharmacy industry. Having held such positions as director of pharmacy, pharmacy supervisor, and general manager, she currently serves Alegria Specialty Pharmacy as an operational consultant. Dedicated to helping others, Ellen Scharaga supports several charitable organizations, including the American Cancer Society.

As part of its mission to end cancer around the world, the American Cancer Society maintains numerous programs and services that help cancer patients and caregivers ease some of their burdens during their battle against cancer.

One such service, the Hope Lodge program, provides patients and their caregivers with a free place to stay while they receive treatment away from home. Hope Lodge was created to alleviate the expense and stress of traveling to obtain treatment, which oftentimes prevents individuals from getting the help they need. Hope Lodge helps patients focus on getting better rather than worrying about paying for lodging.

There are currently more than 30 Hope Lodge locations throughout the United States and Puerto Rico. Although each location varies in terms of eligibility requirements, they all provide guests with a home-like environment and offer various resources related to cancer treatment. Hope Lodges also give guests the option to connect with other patients or to maintain their privacy.

The LLS Praises the FDA’s Approval of Blinatumomab

Blinatumomab pic
Blinatumomab
Image: amgen.com

Melville, NY, resident Ellen Scharaga is committed to helping others. Beyond promoting improved medical patient outcomes through her role as an operational consultant for Alegria Specialty Pharmacy, she supports several charitable organizations. One of the many organizations Ellen Scharaga supports is the Leukemia and Lymphoma Society (LLS).

For more than 65 years, the LLS has been committed to educating the public, helping patients with blood cancer, and funding blood cancer research. The organization recently praised the United States Food and Drug Administration’s approval of blinatumomab as a treatment for individuals with a unique form of acute lymphoblastic leukemia. The therapy, which is a bispecific antibody T-cell engager, directs the body’s T cells to a specific protein found on the surface of B cells, including B-cell lymphomas and leukemias. Modified antibodies then engage a specific target on both the T cell and B cell, forcing the two cells to connect to one another and allowing the T cell to destroy the other cell.

Blinatumomab received the FDA’s Breakthrough Therapy designation in mid-2014 and was approved for patients with refractory B-cell precursor or Philadelphia chromosome-negative relapsed acute lymphoblastic leukemia in early December. The FDA will maintain its approval of the treatment once its clinical benefit is proven through additional research trials.